Pietro Pozzi Selected Research

givinostat hydrochloride

1/2019	Correction to: Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
1/2019	Histone deacetylase inhibitor ITF2357 (givinostat) reverts transformed phenotype and counteracts stemness in in vitro and in vivo models of human glioblastoma.
1/2015	Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.
1/2005	The histone deacetylase inhibitor ITF2357 reduces production of pro-inflammatory cytokines in vitro and systemic inflammation in vivo.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Pietro Pozzi Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 03/2002
2	Autoimmune Diseases (Autoimmune Disease) 01/2022 - 12/2019
2	Glioblastoma (Glioblastoma Multiforme) 01/2019 - 01/2019
1	COVID-19 01/2022
1	Infections 01/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Disease Progression 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2019
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2015
1	Hepatitis 01/2005
1	Inflammation (Inflammations) 01/2005

Drug/Important Bio-Agent (IBA)

5	Histone Deacetylase InhibitorsIBA 01/2022 - 01/2005
4	givinostat hydrochlorideIBA 01/2019 - 01/2005
3	CytokinesIBA 01/2022 - 03/2002
3	Histone Deacetylases (Histone Deacetylase)IBA 01/2019 - 03/2002
3	givinostatIBA 01/2019 - 01/2015
1	EnzymesIBA 01/2022
1	VaccinesIBA 01/2022
1	Protein Isoforms (Isoforms)IBA 12/2019
1	Histone Deacetylase 6IBA 12/2019
1	Concanavalin AIBA 01/2005

Therapy/Procedure

1	Organ Transplantation 12/2019